AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-3.83%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$821M
AUM Growth
+$821M
(+17%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
20.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Denali Therapeutics
DNLI
|
$152M |
| 2 |
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
|
$13.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.38% |
| 2 | Financials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $369M | 44.91% |
2,912,872
| – | – |
|
|
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
| $170M | 20.77% |
36,335,375
| – | – |
|
|
3
Denali Therapeutics
DNLI
$2.23B
| $152M | 18.54% |
+5,168,749
| New | +$152M |
|
4
Erasca
ERAS
$445M
| $61.6M | 7.5% |
11,055,554
| – | – |
|
|
VERV
5
DELISTED
Verve Therapeutics
VERV
| $38.3M | 4.67% |
2,508,809
| – | – |
|
|
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $14.5M | 1.77% |
3,798,926
| – | – |
|
|
REVH
7
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $13.3M | 1.62% |
+1,357,237
| New | +$13.3M |
|
|
MTCR
8
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.47M | 0.18% |
2,940,503
| – | – |
|
|
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
| $298K | 0.04% |
349,908
| – | – |
|
|
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
| $147K | 0.02% |
119,205
| – | – |
|